First patient receives prime editing therapy for Wilson's disease
Prime editing – a type of genome editing – has been used to alter DNA directly inside a person's body for the first time...
The Food and Drug administration is a US federal agency responsible for protecting public health. It is the body responsible for regulation and approval of drugs and other pharmaceutical products such as vaccines within the USA.
Prime editing – a type of genome editing – has been used to alter DNA directly inside a person's body for the first time...
A gene therapy for Huntington's disease failed to show statistically significant slowing of disease progression after 48 months, according to newly released data...
A Phase 2/3 trial assessing a gene therapy for X-linked retinitis pigmentosa (XLRP) shows significant improvements in low-light vision...
by BioNews
A CRISPR-based therapy continues to reduce harmful cholesterol levels in patients after a one-year follow-up in a Phase 1 clinical trial...
New evidence on the risks of gestational surrogacy should strengthen the case for better safeguards, writes Dr Carole Gilling-Smith...
The US Food and Drug Administration (FDA) has put a clinical hold on an experimental gene therapy for Hunter syndrome due to nodules being discovered in the spine of five patients who previously received treatment...
The US Food and Drug Administration is allowing biotech company uniQure to reapply for the licensing of a gene therapy that could slow the progression of Huntington's disease...
A new experimental gene therapy has shown early success in treating a rare genetic epilepsy syndrome...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.